Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
CALL
Magna International
MGA
$18.8B
| $14M | ﹤0.01% |
255,400
+22,500
| +10% | +$1.37M |
|
2177
PUT
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $14M | ﹤0.01% |
169,300
-246,500
| -59% | -$20.4M |
|
2178
Integra LifeSciences
IART
$1.43B
| $14M | ﹤0.01% |
259,104
+59,329
| +30% | +$3.56M |
|
2179
United Therapeutics
UTHR
$21.4B
| $14M | ﹤0.01% |
59,353
-174,171
| -75% | -$35.4M |
|
2180
Bausch Health
BHC
$2.43B
| $14M | ﹤0.01% |
1,672,536
+517,280
| +45% | +$7.23M |
|
|
SWAV
2181
CALL
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $14M | ﹤0.01% |
73,100
+23,400
| +47% | +$4.13M |
|
2182
PUT
Kinder Morgan
KMI
$73.1B
| $14M | ﹤0.01% |
833,700
+32,100
| +4% | +$601K |
|
2183
Tenaris
TS
$27B
| $14M | ﹤0.01% |
543,712
-362,996
| -40% | -$11.2M |
|
2184
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
| $13.9M | ﹤0.01% |
126,662
+3,427
| +3% | +$378K |
|
2185
MoonLake Immunotherapeutics
MLTX
$1.4B
| $13.9M | ﹤0.01% |
2,702,661
+2,003,765
| +287% | +$12.6M |
|
|
SQSP
2186
DELISTED
Squarespace, Inc.
SQSP
| $13.9M | ﹤0.01% |
664,700
+541,292
| +439% | +$11.6M |
|
2187
Installed Building Products
IBP
$6.39B
| $13.9M | ﹤0.01% |
167,185
+118,904
| +246% | +$10.2M |
|
2188
PUT
TripAdvisor
TRIP
$1.26B
| $13.9M | ﹤0.01% |
779,100
-297,800
| -28% | -$7.06M |
|
2189
VanEck Junior Gold Miners ETF
GDXJ
$8.49B
| $13.9M | ﹤0.01% |
+433,194
| New | +$17.8M |
|
|
BRSL
2190
CALL
Brightstar Lottery PLC
BRSL
$2.15B
| $13.8M | ﹤0.01% |
746,200
-21,300
| -3% | -$454K |
|
2191
Castle Biosciences
CSTL
$905M
| $13.8M | ﹤0.01% |
630,596
+443,589
| +237% | +$10.3M |
|
2192
AMN Healthcare
AMN
$1.34B
| $13.8M | ﹤0.01% |
126,100
-68,627
| -35% | -$6.79M |
|
2193
HEICO Corp Class A
HEI.A
$38.4B
| $13.8M | ﹤0.01% |
130,973
-9,416
| -7% | -$1.08M |
|
2194
PUT
Weyerhaeuser
WY
$17.7B
| $13.8M | ﹤0.01% |
416,500
-191,700
| -32% | -$7.31M |
|
2195
Remitly
RELY
$5.54B
| $13.8M | ﹤0.01% |
1,796,888
-889,030
| -33% | -$8.81M |
|
2196
Healthcare Services Group
HCSG
$1.48B
| $13.7M | ﹤0.01% |
789,124
+210,186
| +36% | +$3.62M |
|
2197
CALL
Unum
UNM
$14.8B
| $13.7M | ﹤0.01% |
403,800
+194,900
| +93% | +$6.6M |
|
2198
CALL
Invesco CurrencyShares Euro Currency Trust
FXE
$342M
| $13.7M | ﹤0.01% |
141,500
+37,200
| +36% | +$3.67M |
|
2199
Service Corp International
SCI
$11.5B
| $13.7M | ﹤0.01% |
198,085
+117,883
| +147% | +$8.06M |
|
2200
CALL
Insulet
PODD
$9.94B
| $13.7M | ﹤0.01% |
62,800
+24,700
| +65% | +$5.61M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.